Request Appointment
535 E 68th StNew York, NY 10065
Overview of Dr. Barbieri
Dr. Christopher Barbieri is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 10 years. He is one of 191 doctors at New York-Presbyterian Hospital and one of 65 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Urology. He has more than 100 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2009 - 2013- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2007 - 2009
Vanderbilt University School of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2009 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- MetLife Clinical Investigator Award Damon Runyon Cancer Research Foundation, 2016
- Rising Star in Urology Research Urology Care Foundation / AUA, 2015
- Challenge Award Prostate Cancer Foundation, 2014
- Join now to see all
Publications & Presentations
PubMed
- Direct measurement of the male germline mutation rate in individuals using sequential sperm samples.Jonathan E Shoag, Amoolya Srinivasa, Caitlin A Loh, Mei Hong Liu, Emilie Lassen
Nature Communications. 2025-03-15 - 1 citationsGenomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer.Philip Sutera, Yang Song, Amol C Shetty, Keara English, Kim Van der Eecken
European Urology Oncology. 2025-02-01 - 1 citationsCanonical androgen response element motifs are tumor suppressive regulatory elements in the prostate.Xuanrong Chen, Michael A Augello, Deli Liu, Kevin Lin, Alex Hakansson
Nature Communications. 2024-12-13
Journal Articles
- Impact of Pelvic Radiation Therapy on Inflatable Penile Prosthesis Reoperation RatesChristopher E Barbieri, James A Kashanian, The Journal of Sexual Medicine
- Introduction to “Molecular Drivers of Prostate Cancer Development, Progression, and Resistance to Therapy”Christopher Barbieri, MD, Urologic Oncology
- Molecular Subtypes of Prostate CancerChristopher Barbieri, MD, Current Oncology Reports
Authored Content
- SPOP Mutated/ CHD1 Deleted Lethal Prostate Cancer and Abiraterone SensitivityMarch 2018
Press Mentions
Putting the Brakes on Prostate Cancer CellsDecember 13th, 2024- What You Need to Know About Prostate Cancer TreatmentsOctober 7th, 2024
- Prostate Cancer’s Spread Modeled with CRISPR Barcoding TechnologySeptember 23rd, 2024
- Join now to see all
Grant Support
- Growth suppressive and oncogenic transcriptional programs controlled by the androgen receptor in prostate cancerWEILL MEDICAL COLL OF CORNELL UNIV2025–2030
- Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancerWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancerWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancerWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Collaborative genomic alterations and transcriptional control in prostate cancerWEILL MEDICAL COLL OF CORNELL UNIV2019–2025
- Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate CancerWEILL MEDICAL COLL OF CORNELL UNIV2018–2025
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
